Regencor is a privately held regenerative medicine company spun out of Stanford University, advancing first in class treatments for cardiovascular disease...
Regencor's team envisions a future in which myocardial infarctions no longer impose incurable & life-threatening tissue damage or progression to heart failure...
Pioneering development of cutting-edge therapeutics to repair tissue damage and to restore cardiac function following myocardial infarction.